Gilead Sciences is a biotechnology company that delivers life-saving therapies to patients every day. The company researches, develops, and commercializes drugs that are primarily used to treat HIV, hepatitis B, hepatitis C, and influenza. With over 11,000 employees, Gilead Sciences is developing the next generation of innovative therapies to help millions of people to live healthier, more fulfilling lives.
62 Reviews
Fast paced good colleagues to work with and good amenities on site
Management is inexperienced and has a culture of promotion for inner circle
New Jersey, United States - The Global Atrial Fibrillation Drugs Market is researched with
MacroGenics shares are trading higher after the company announced an exclusive option and collaboration agreement with Gilead Sciences to develop MGD024. Gilead will pay MacroGenics an upfront payment of $60 million. - Macrogenics (NASDAQ:MGNX Benzinga